KDR and posterior cortical atrophy: To determine the expression of selected cabozantinib targets in PCa, we evaluated levels of MET, murine VEGFR2, AXL, KIT, and RET mRNA in 24 different LuCaP PCa xenografts that closely model the heterogeneity of PCa in humans [37].